Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2006; 12(39): 6331-6338
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6331
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6331
Figure 1 Reasons for exclusion.
pts: patients.
Figure 2 Actuarial curves of patients free from gastroesophageal rebleeding after distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES).
P < 0.05 vs ES using the log-rank test.
Figure 3 Actuarial survival curves for distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES).
DSRS vs ES for the first 5 years (breslow test P = 0.038) while no differences were found in the final outcome (log rank test P = 0.1168)
- Citation: Santambrogio R, Opocher E, Costa M, Bruno S, Ceretti AP, Spina GP. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: A lesson from the past. World J Gastroenterol 2006; 12(39): 6331-6338
- URL: https://www.wjgnet.com/1007-9327/full/v12/i39/6331.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i39.6331